Intravitreal Ranibizumab Injections Safely, Effectively Treat Non-AMD CNV
Intravitreal ranibizumab showed potential benefit and a high safety profile in the treatment of choroidal neovascularization resulting from causes other than age-related macular degeneration, a study found.